| Ytd | -23.44% | |
| 1y | -17.08% |
| Open | 5.15 | Prev Close | 5.14 | Low | 5.11 | High | 5.29 | Mkt Cap | 73.50M |
| Vol | 0.00 | Avg Vol | 9.02K | EPS | -0.16 | P/E | -33.06 | Forward P/E | 42.68 |
| Beta | 0.40 | Short Ratio | 20.86 | Inst. Own | 49.09% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 03-12 | 50-d Avg | 5.91 | 200-d Avg | 6.26 | 1yr Est | 8.00 |
Champions Oncology reports fourth-quarter fiscal 2026 growth as revenue gains, margin improvement an
Champions Oncology, Inc. (CSBR) Q4 2026 Earnings Call Transcript
Champions Oncology NASDAQ: CSBR reported record revenue for fiscal 2026 and positive adjusted EBITDA
Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.01 per share which beat the analy
Delivers Fourth Consecutive Quarter of Positive Adjusted EBITDA HACKENSACK, NJ / ACCESS Newswire / J
Champions Oncology and Cytek Biosciences have different growth drivers and valuations, but which lif
CSBR and CEPL have levers in place for Gross Margin improvement.
Discover why Zacks rates Champions Oncology as "Neutral", being the first on Wall Street to initiate
HACKENSACK, NJ / ACCESS Newswire / July 20, 2026 / Champions Oncology, Inc. (NASDAQ:CSBR), a global
Champions Oncology, Inc. (NASDAQ: CSBR - Get Free Report) shares passed below its two hundred day mo
Eight studies demonstrate how clinically relevant models and integrated data can reduce translationa
Appointment underscores Champions' focus on leveraging clinically relevant data to power next-genera
Champions Oncology, Inc. (CSBR) Q3 2026 Earnings Call Transcript
Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.04 per share which missed the ana
Company remains on track to deliver year-over-year revenue growth and positive adjusted EBITDA for t
HACKENSACK, NJ / ACCESS Newswire / March 5, 2026 / Champions Oncology, Inc. (CSBR), a leading transl
Champions Oncology, Inc. (CSBR) Q2 2026 Earnings Call Transcript
Stock News Ford pivots from full EV to hybrids and storage: Ford Motor (F) will discontinue the allâ
Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.06 per share which beat the analy
We remain on track to deliver year-over-year revenue growth and to generate positive adjusted EBITDA
Investors are prepping for this week's earnings reports which include homebuilders, several appa
Stock News iRobot enters Chapter 11: iRobot (IRBT) filed for Chapter 11 and agreed to be acquired by
U.S. stocks fell on Friday, with the S&P 500 dropping over 1% and the Dow gaining 1.1%. The Fear and
U.S. stocks fell on Friday, with the S&P 500 dropping over 1% and the Dow gaining 1.1%. The Fear
Stock futures up, focus on HYFT, ARGX, NAVN, AXR, CSBR as they report earnings. Top 2 energy stocks
HACKENSACK, NJ / ACCESS Newswire / December 8, 2025 / Champions Oncology, Inc. (CSBR), a leading tra
Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.02 per share which beat the analy
Several biotech stocks have seen their strength fade over the past week, with their Momentum scores
Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for it
Companies Reporting Before The Bell • CSP (NASDAQ:CSPI) is likely to report earnings for its fourth
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly
Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ:IDYA) is likely to report quart
Companies Reporting Before The Bell • Champions Oncology, Inc. - Common Stock (NASDAQ:CSBR) is e
This morning 279 companies reached new 52-week highs.
Companies Reporting Before The Bell • Celsius Holdings (NASDAQ:CELH) is estimated to report quar
Companies Reporting Before The Bell • Hasbro Inc. (NASDAQ:HAS) is expected to report quarterly earn
Stocks That Hit 52-Week Lows On Monday
Stocks Which Set New 52-Week High Friday, September 14th